Who to call at CGBIO, and when
Fundz watches for the moments CGBIO starts buying, and tells you who to reach.
- An alert the day CGBIO raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CGBIO, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CGBIO. With Fundz connected, it knows.
Contract Type
partnership
South KoreaManufacturingBiotechnologyHealth CareMedicalMedical DeviceDescription
CGBio has entered into a partnership with Hallym University Kangnam Sacred Heart Hospital to establish a training center for robotic spine surgery. The collaboration will focus on improving training methodologies and standardizing procedures in biportal endoscopic spine surgery.
Quick answer
CGBio Partners with Hallym Hospital to Enhance Robotic Spine Surgery Training. (November 9, 2026). CGBIO is based in South Korea.
- What agreement did CGBIO announce on November 9, 2026?
- CGBio has entered into a partnership with Hallym University Kangnam Sacred Heart Hospital to establish a training center for robotic spine surgery. The collaboration will focus on improving training methodologies and standardizing procedures in biportal endoscopic spine surgery.
- What does CGBIO do?
- CGBIO is a leading biotechnology firm specializing in regenerative medicine.
- Where is CGBIO based?
- CGBIO is based in South Korea.
- Which similar companies announced agreements around the same time?
- Medtronic plc (November 7, 2026), Becton Dickinson (November 5, 2026), Abbott Laboratories (November 5, 2026) and JD Technologies Global (November 4, 2026) also announced agreements within 45 days of CGBIO.
Source: Fundz verified event record.
Other recent agreements in Medical and Medical Device
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- Medtronic announces partnership with the Michael J. Fox Foundation to enhance education on deep brain stimulation for Parkinson's disease. (November 7, 2026)
- Becton Dickinson Announces $19B Manufacturing Partnership with U.S. Government to Boost Domestic Medical Production. (November 5, 2026)
- Abbott partners with Novo to enhance access to Plosbrio® for advanced diabetes care in Asia Pacific. (November 5, 2026)
- JD Technologies Global and FRIWO North America Form Strategic Partnership to Enhance U.S. Medical Market Access (November 4, 2026)
- Boston Scientific and Heartflow Form Strategic Partnership to Enhance PCI Planning. (October 28, 2026)
- OncoBeta and Mediray Partner to Introduce Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Anticancer Hospital. (November 6, 2026)
Agreement Insights
What this usually meansCGBIO signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.